X4 Pharmaceuticals Inc. (XFOR) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    X4 Pharmaceuticals Inc.

    NASDAQ: XFOR · Real-Time Price · USD
    3.30
    -0.09 (-2.65%)
    At close: Sep 11, 2025, 3:59 PM
    3.26
    -1.16%
    After-hours: Sep 11, 2025, 07:16 PM EDT

    X4 Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 55.7M 99.22M 121.72M 81.79M
    Short-Term Investments
    		 46.36M 15M n/a n/a
    Long-Term Investments
    		 n/a 782K 1.02M 1.32M
    Other Long-Term Assets
    		 2.08M 654K 1.23M 1.72M
    Receivables
    		 1.71M 562K 1.15M 747K
    Inventory
    		 2.82M n/a n/a n/a
    Other Current Assets
    		 5.59M 7.3M 5.81M n/a
    Total Current Assets
    		 112.17M 122.08M 128.68M 87.88M
    Property-Plant & Equipment
    		 4.84M 6.39M 8.33M 10.22M
    Goodwill & Intangibles
    		 27.35M 17.35M 17.35M 17.35M
    Total Long-Term Assets
    		 34.27M 25.18M 26.91M 29.3M
    Total Assets
    		 146.45M 147.26M 155.59M 117.18M
    Account Payables
    		 8.62M 8.95M 7.78M 4.28M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a 1.1M 1.31M 795K
    Other Current Liabilities
    		 13.05M 7.1M 6.59M 5.42M
    Total Current Liabilities
    		 32.88M 22.86M 22.32M 14.02M
    Long-Term Debt
    		 75.42M 54.57M 32.3M 33.14M
    Other Long-Term Liabilities
    		 14.59M 16.11M 23.3M 826K
    Total Long-Term Liabilities
    		 91.42M 73.3M 59.21M 38.74M
    Total Liabilities
    		 124.3M 96.16M 81.53M 52.76M
    Total Debt
    		 78.09M 58.28M 38.42M 39.78M
    Common Stock
    		 171K 167K 122K 28K
    Retained Earnings
    		 -515.36M -477.9M -376.74M -282.87M
    Comprehensive Income
    		 -122K -119K -119K -119K
    Shareholders Equity
    		 22.15M 51.1M 74.05M 64.41M
    Total Investments
    		 46.36M 15M 1.02M 1.32M

    Add to Watchlist